Conclusion
hypoglycemia, atherogenesis
HYPOGLYCEMIA, CVD
Our study has indicated that beinaglutide improved glycemic control with a low risk of hypoglycemia and low titers of beinaglutide ADAs. In addition, beinaglutide reduced non-fasting TG, slowing atherogenesis and the progression of CVD 